|
End-of-day quote
Ghana S.E.
|
||
| - GHS | - |
|
| Market Cap | 5.2M 60.55M 4.65M 4.28M 3.88M 7.25M 493M 7.39M 51.05M 20.49M 260M 19.5M 19.09M 818M | P/E 2017 |
11.7x | P/E 2018 | 6.9x |
|---|---|---|---|---|---|
| Enterprise Value | 10.45M 122M 9.36M 8.61M 7.8M 14.58M 992M 14.85M 103M 41.2M 522M 39.2M 38.37M 1.65B | EV / Sales 2017 |
1.34x | EV / Sales 2018 | 1.05x |
| Free-Float |
26.89% | Yield 2017 * |
-
| Yield 2018 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 915K | |
| +3.19% | +11.31% | +67.86% | +150.58% | 1,263B | |
| -0.73% | +3.56% | +44.51% | +85.81% | 658B | |
| +1.41% | +3.24% | +29.22% | +107.83% | 521B | |
| +0.42% | +3.20% | +54.15% | +67.18% | 391B | |
| +2.18% | +2.93% | +73.30% | +45.62% | 369B | |
| +1.12% | +4.52% | +35.30% | +58.08% | 307B | |
| +6.96% | +8.86% | +11.27% | +36.62% | 290B | |
| +1.15% | +6.09% | +59.59% | +77.06% | 252B | |
| +3.06% | +9.38% | +44.11% | +119.47% | 212B | |
| Average | +1.73% | +5.90% | +46.59% | +83.14% | 426.19B | |
| Weighted average by Cap. | +1.19% | +6.60% | +50.88% | +98.31% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 8.89M 104M 7.96M 7.33M 6.64M 12.41M 844M 12.64M 87.36M 35.07M 444M 33.37M 32.66M 1.4B | 9.91M 115M 8.87M 8.16M 7.4M 13.83M 941M 14.09M 97.35M 39.08M 495M 37.19M 36.4M 1.56B |
| Net income | 665K 7.75M 596K 548K 496K 928K 63.15M 945K 6.53M 2.62M 33.22M 2.5M 2.44M 105M | 762K 8.87M 682K 627K 568K 1.06M 72.31M 1.08M 7.48M 3M 38.04M 2.86M 2.8M 120M |
| Net Debt | 4.15M 48.32M 3.71M 3.42M 3.1M 5.79M 394M 5.89M 40.74M 16.35M 207M 15.56M 15.23M 653M | 5.25M 61.17M 4.7M 4.32M 3.92M 7.32M 498M 7.46M 51.57M 20.7M 262M 19.7M 19.28M 827M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- SPL Stock
Select your edition
All financial news and data tailored to specific country editions
